VYGR Voyager Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$2.45
· of 52w range
· above low
· to high
$2.4252w low
$5.5552w high
Market Cap (MRQ)
$150M
P/E (TTM)
-1.4
EPS (TTM)
$-1.81
Revenue (TTM)
$34M
your badges
52W Range
$2–$6
Analyst Rating
STRONG BUY
Price Target
$15
P/E
-1.4
ROE
-54.1%
Net Profit Margin
-312.6%
Your badge strip is empty — pin a metric anywhere on this page.
VYGR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.45
Market Cap (MRQ)
$150M
P/E (TTM)
-1.4
EPS (TTM)
$-1.81
Revenue (TTM)
$34M
ROE (TTM)
-54.1%
52W Range
$2–$6
VYGR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Voyager Therapeutics, Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees141
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$40M2016-12-31 → 2025-12-31
EPS$-2.042018-12-31 → 2025-12-31
Free Cash Flow$-135M2016-12-31 → 2025-12-31
Net margin-312.6%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | VYGR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.45Y avg ≈-2.1 | ≈-2.1 | · | · | |
| P/S (TTM) | 4.45Y avg ≈3.9 | ≈3.9 | 6.4 | Fair value | |
| P/B (MRQ) | 1.05Y avg ≈1.8 | ≈1.8 | 2.6 | Undervalued | |
| Price / FCF (TTM) | -1.25Y avg ≈-6.2 | ≈-6.2 | · | · | |
| Price / Cash Flow (TTM) | -1.25Y avg ≈-7.6 | ≈-7.6 | · | · | |
| Price / Tangible Book | 0.75Y avg ≈1.8 | ≈1.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | VYGR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -340.1%5Y avg ≈-140.6% | ≈-140.6% | -314.1% | Weak | |
| EBITDA Margin | -326.6%5Y avg ≈-140.6% | ≈-140.6% | -215.3% | Weak | |
| Pretax Margin (TTM) | -312.3%5Y avg ≈-109.1% | ≈-109.1% | -772.6% | In line | |
| Net Profit Margin (TTM) | -312.6%5Y avg ≈-125.7% | ≈-125.7% | -536.3% | Below avg | |
| ROA (TTM) | -41.4%5Y avg ≈-12.1% | ≈-12.1% | -55.2% | Top tier | |
| ROE (TTM) | -54.1%5Y avg ≈-31.2% | ≈-31.2% | -60.0% | In line | |
| ROIC | -67.3%5Y avg ≈-32.6% | ≈-32.6% | -60.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | VYGR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.55Y avg ≈4.5 | ≈4.5 | 8.1 | Low liquidity | |
| Quick Ratio (MRQ) | 7.15Y avg ≈4.4 | ≈4.4 | 7.8 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | VYGR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -49.5%5Y avg ≈65.0% | ≈65.0% | · | · | |
| Revenue CAGR 3Y | -0.44%5Y avg ≈14.0% | ≈14.0% | · | · | |
| Revenue CAGR 5Y | -25.1% | · | · | · | |
| EPS CAGR 3Y | 44.7% | · | · | · | |
| Net Income CAGR 3Y | 53.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | VYGR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.3 | ≈0.3 | 0.1 | Top tier | |
| Receivables Turnover | 24.75Y avg ≈11.0 | ≈11.0 | 14.1 | Top tier | |
| Revenue / Employee | ≈$286.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
6.1%
Next Report
Nov 08, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 4, 2026 | $-0.40 | $-0.49 | 19.0% |
| March 31, 2026 | May 12, 2026 | $-0.47 | $-0.56 | 16.4% |
| Dec. 31, 2025 | $-0.46 | $-0.52 | 11.7% | |
| Sept. 30, 2025 | $-0.47 | $-0.53 | 11.5% | |
| June 30, 2025 | $-0.57 | $-0.54 | -6.3% | |
| March 31, 2025 | $-0.53 | $-0.46 | -15.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40M | $80M | $250M | $41M | $37M | $171M | $104M | $8M | $10M | $14M | $17M | |
| R&D Expense | $135M | $127M | $92M | $61M | $74M | $109M | $120M | $65M | $62M | $42M | $28M | |
| SG&A Expense | $38M | $36M | $36M | $31M | $37M | $35M | $36M | $34M | $20M | $13M | $10M | |
| Operating Expenses | $172M | $163M | $128M | $92M | $111M | $144M | $156M | $99M | $82M | $56M | $38M | |
| Operating Income | $-132M | $-83M | $122M | $-51M | $-74M | $27M | $-52M | $-91M | $-72M | $-41M | $-20M | |
| Other Non-op | $2M | $622.0K | $3.0K | $3M | $3M | $8M | $2M | $-683.0K | $-62.0K | $182.0K | $-10M | |
| Pretax Income | $-120M | $-64M | $134M | $-46M | $-71M | $37M | $-44M | $-88M | $-71M | $-40M | $-30M | |
| Income Tax | $144.0K | $665.0K | $1M | $16.0K | · | · | · | $-180.0K | · | $52.0K | $0 | |
| Net Income | $-120M | $-65M | $132M | $-46M | $-71M | $37M | $-44M | $-88M | $-71M | $-40M | $-30M | |
| EPS (Basic) | $-2.04 | $-1.13 | $3.08 | $-1.21 | $-1.89 | $0.99 | $-1.21 | $-2.75 | · | · | · | |
| EPS (Diluted) | $-2.04 | $-1.13 | $2.97 | $-1.21 | $-1.89 | $0.98 | $-1.21 | $-2.75 | · | · | · | |
| Shares (Basic) | 58,691,136 | 57,667,543 | 43,020,747 | 38,356,810 | 37,668,947 | 37,132,447 | 35,898,266 | 32,065,781 | · | · | · | |
| Shares (Diluted) | 58,691,136 | 57,667,543 | 44,569,334 | 38,356,810 | 37,668,947 | 37,348,514 | 35,898,266 | 32,065,781 | · | · | · | |
| EBITDA | $-132M | $-83M | $122M | $-51M | $-74M | $27M | $-52M | $-91M | $-72M | $-41M | $-20M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $71M | $69M | $99M | $117M | $104M | $86M | $47M | $32M | $37M | $31M | |
| Short-term Investments | $131M | $195M | $162M | $20M | $15M | $77M | $195M | $109M | $138M | · | · | |
| Receivables | $2M | $2M | $80M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $8M | $5M | $5M | $3M | $9M | $5M | $7M | $3M | $4M | $2M | |
| Other Current Assets | $2M | $3M | $3M | $4M | $2M | $2M | $1M | $1M | $766.0K | $2M | $424.0K | |
| Current Assets | $203M | $277M | $320M | $124M | $137M | $198M | $305M | $162M | $172M | $179M | $196M | |
| PP&E (Net) | $13M | $14M | $16M | $18M | $22M | $25M | $18M | $13M | $10M | $8M | $3M | |
| PP&E (Gross) | $32M | $30M | $32M | $35M | $38M | $37M | $26M | $18M | $13M | $9M | $4M | |
| Accum. Depreciation | $19M | $16M | $15M | $17M | $16M | $12M | $8M | $5M | $3M | $1M | $784.0K | |
| Total Assets | $252M | $393M | $351M | $159M | $194M | $262M | $355M | $177M | $184M | $190M | $229M | |
| Accounts Payable | $5M | $4M | $2M | $3M | $574.0K | $634.0K | $4M | $1M | $1M | $550.0K | $612.0K | |
| Accrued Liabilities | $12M | $14M | $17M | $8M | $11M | $14M | $22M | $10M | $11M | $6M | $3M | |
| Current Liabilities | $27M | $50M | $65M | $73M | $51M | $27M | $76M | $32M | $16M | $14M | $24M | |
| Capital Leases | $29M | $36M | $17M | $20M | $39M | $43M | $31M | · | · | · | · | |
| Other Non-current Liabilities | · | $37M | $18M | $21M | $40M | $44M | $32M | $7M | $1M | $25.0K | $44.0K | |
| Total Liabilities | $56M | $93M | $115M | $100M | $99M | $107M | $255M | $131M | $50M | $54M | $60M | |
| Common Stock | $59.0K | $55.0K | $44.0K | $38.0K | $38.0K | $37.0K | $37.0K | $32.0K | $32.0K | $26.0K | $25.0K | |
| Paid-in Capital | $642M | $626M | $498M | $453M | $442M | $430M | $412M | $316M | $295M | $226M | $219M | |
| Retained Earnings | $-446M | $-326M | $-261M | $-394M | $-347M | $-276M | $-313M | $-269M | $-161M | $-90M | $-50M | |
| AOCI | $32.0K | $-407.0K | $-48.0K | $-219.0K | $-138.0K | $-134.0K | $-104.0K | $-133.0K | $-287.0K | $-52.0K | $-251.0K | |
| Stockholders' Equity | $196M | $300M | $236M | $59M | $95M | $154M | $100M | $46M | $134M | $136M | $169M | |
| Liabilities + Equity | $252M | $393M | $351M | $159M | $194M | $262M | $355M | $177M | $184M | $190M | $229M | |
| Shares Outstanding | 59,047,860 | 54,731,316 | 44,038,333 | 38,613,891 | 37,918,395 | 37,368,027 | 36,865,116 | 32,364,895 | 31,572,044 | 25,597,912 | 24,930,979 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $15M | $11M | $9M | $11M | $15M | $16M | $16M | $9M | $6M | $4M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $-128.0K | · | |
| Operating Cash Flow | $-132M | $-15M | $78M | $-13M | $-54M | $-97M | $49M | $-16M | $-61M | $-42M | $41M | |
| CapEx | $3M | $4M | $3M | $2M | $2M | $12M | $8M | $4M | $4M | $5M | $1M | |
| Investing Cash Flow | $125M | $-95M | $-142M | $-7M | $66M | $113M | $-90M | $26M | $-4M | $48M | $-195M | |
| Stock Issued | · | $93M | · | · | · | · | · | · | $58M | · | · | |
| Net Stock Activity | · | $93M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $816.0K | $114M | $34M | $1M | $612.0K | $3M | $81M | $5M | $60M | $514.0K | $178M | |
| Net Change in Cash | $-6M | $4M | $-30M | $-19M | $13M | $19M | $39M | $15M | $-5M | $6M | $24M | |
| Taxes Paid | $714.0K | $1M | $16.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-135M | $-19M | $75M | $-15M | $-55M | $-109M | $41M | $-20M | $-65M | $-48M | $40M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% | 16.0% | -49.5% | -1195.6% | -709.1% | -290.4% | -116.9% | |
| Net Margin | -296.5% | -81.2% | 52.9% | -113.5% | -190.3% | 21.5% | -41.8% | -1158.8% | -697.6% | -282.6% | -171.2% | |
| Pretax Margin | -296.2% | -80.4% | 53.5% | -113.4% | · | 21.5% | -41.8% | -1161.1% | -697.6% | -282.3% | · | |
| EBITDA Margin | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% | 16.0% | -49.5% | -1195.6% | -709.1% | -290.4% | -116.9% | |
| ROA | -37.1% | -17.5% | 51.8% | -26.3% | -31.3% | 11.9% | -16.4% | -48.8% | -37.8% | -19.2% | -24.6% | |
| ROE | -54.4% | -20.6% | 64.1% | -66.8% | -78.0% | 22.9% | -42.0% | -157.6% | -52.4% | -26.4% | -40.0% | |
| ROIC | -67.3% | -28.1% | 51.1% | -86.2% | · | · | · | -195.7% | · | -30.4% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 5.6 | 5.0 | 1.7 | 2.7 | 7.4 | 4.0 | 5.1 | 10.8 | 13.0 | 8.2 | |
| Quick Ratio | 7.5 | 5.4 | 4.8 | 1.6 | 2.6 | 6.8 | 3.7 | 4.9 | 2.0 | 2.7 | 1.3 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 1.0 | 0.2 | 0.2 | 0.6 | 0.4 | 0.0 | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | 24.7 | 2.0 | 6.2 | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.32 | $5.48 | $5.37 | $1.53 | $2.51 | $4.13 | $2.70 | $1.44 | $4.25 | $5.31 | $6.78 | |
| Revenue / Share | $0.69 | $1.39 | $5.61 | $1.07 | $0.99 | $4.58 | · | · | · | · | · | |
| Cash Flow / Share | $-2.26 | $-0.27 | $1.75 | $-0.33 | $-1.42 | $-2.59 | · | · | · | · | · | |
| Cash / Share | $1.11 | $1.30 | $1.56 | $2.56 | $3.10 | $2.79 | $2.33 | $1.45 | $1.00 | $1.43 | $1.26 | |
| Dividend / Share | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | |
| Dividend Paid / Share | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | |
| EPS (TTM) | $-2.04 | $-1.13 | $2.97 | $-1.21 | $-1.89 | $0.98 | $-1.21 | $-2.75 | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -49.5% | -68.0% | 511.2% | 9.3% | -78.1% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.44% | 28.8% | 13.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -25.1% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 44.7% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 53.3% | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $40M | $80M | $250M | $41M | $37M | $171M | $104M | $8M | $10M | $14M | $17M | |
| Net Income TTM | $-120M | $-65M | $132M | $-46M | $-71M | $37M | $-44M | $-88M | $-71M | $-40M | $-30M | |
| Market Cap | $232M | $310M | $372M | $236M | $103M | $267M | $514M | $304M | $524M | $326M | $546M | |
| P/E | -1.9 | -5.0 | 2.8 | -5.0 | -1.4 | 7.3 | -11.5 | -3.4 | · | · | · | |
| P/S | 5.7 | 3.9 | 1.5 | 5.8 | 2.7 | 1.6 | 4.9 | 39.9 | 51.7 | 22.9 | 31.5 | |
| P/B | 1.2 | 1.0 | 1.6 | 4.0 | 1.1 | 1.7 | 5.2 | 6.6 | 3.9 | 2.4 | 3.2 | |
| P / Tangible Book | 1.2 | 1.0 | 1.6 | 4.0 | 1.1 | 1.7 | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -20.3 | 4.8 | -18.8 | -1.9 | -2.8 | 10.6 | -19.1 | -8.5 | -7.7 | 13.2 | |
| P / FCF | -1.7 | -16.5 | 5.0 | -15.7 | -1.9 | -2.5 | 12.6 | -15.1 | -8.0 | -6.9 | 13.6 | |
| Earnings Yield | -51.9% | -19.9% | 35.2% | -19.8% | -69.7% | 13.7% | -8.7% | -29.3% | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $15M | $13M | $5M | $6M | $6M | $25M | $30M | $20M | $90M | $5M | $5M | $150M | $41M | $712.0K | |
| R&D Expense | $22M | $25M | $36M | $36M | $31M | $32M | $36M | $30M | $34M | $27M | $26M | $26M | $22M | $19M | $19M | $13M | |
| SG&A Expense | $8M | $8M | $9M | $8M | $10M | $10M | $9M | $8M | $10M | $9M | $10M | $8M | $8M | $9M | $7M | $8M | |
| Operating Expenses | $30M | $33M | $45M | $44M | $42M | $41M | $45M | $38M | $45M | $36M | $36M | $34M | $30M | $28M | $27M | $20M | |
| Operating Income | $-26M | $-30M | $-30M | $-31M | $-37M | $-35M | $-38M | $-14M | $-15M | $-16M | $54M | $-30M | $-25M | $123M | $14M | $-19M | |
| Other Non-op | $411.0K | $435.0K | $404.0K | $400.0K | $427.0K | $418.0K | $-4M | $200.0K | $20.0K | $5M | $0 | $0 | $3.0K | $2M | $3M | $61.0K | |
| Pretax Income | $-24M | $-28M | $-27M | $-28M | $-33M | $-31M | $-34M | $-9M | $-10M | $-11M | $57M | $-26M | $-22M | $125M | $18M | $-19M | |
| Income Tax | $20.0K | $14.0K | $9.0K | $83.0K | $15.0K | $37.0K | $584.0K | $43.0K | $24.0K | $14.0K | $822.0K | $-177.0K | $59.0K | $704.0K | · | · | |
| Net Income | $-24M | $-28M | $-27M | $-28M | $-33M | $-31M | $-34M | $-9M | $-10M | $-11M | $56M | $-26M | $-22M | $124M | $18M | $-19M | |
| EPS (Basic) | $-0.40 | $-0.47 | $-0.47 | $-0.47 | $-0.57 | $-0.53 | $-0.59 | $-0.16 | $-0.18 | $-0.20 | $1.13 | $-0.59 | $-0.51 | $3.05 | $0.46 | $-0.50 | |
| EPS (Diluted) | $-0.40 | $-0.47 | $-0.47 | $-0.47 | $-0.57 | $-0.53 | $-0.59 | $-0.16 | $-0.18 | $-0.20 | $1.13 | $-0.59 | $-0.51 | $2.94 | $0.45 | $-0.50 | |
| Shares (Basic) | 60,547,863 | 59,496,329 | · | 58,803,015 | 58,666,460 | 58,349,769 | · | 57,851,110 | 57,721,934 | 57,117,046 | · | 43,864,838 | 43,520,137 | 40,632,087 | 38,507,542 | 38,298,426 | |
| Shares (Diluted) | 60,547,863 | 59,496,329 | · | 58,803,015 | 58,666,460 | 58,349,769 | · | 57,851,110 | 57,721,934 | 57,117,046 | · | 43,864,838 | 43,520,137 | 42,161,326 | 39,570,394 | 38,298,426 | |
| EBITDA | $-26M | $-30M | · | $-31M | $-37M | $-35M | · | $-14M | $-15M | $-16M | · | $-30M | $-25M | $123M | $14M | $-19M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $43M | $65M | $45M | $44M | $75M | $71M | $113M | $76M | $143M | · | $65M | $244M | $268M | $97M | $78M | |
| Short-term Investments | $81M | $98M | $131M | $164M | $172M | $161M | $195M | $233M | $295M | $256M | · | $188M | $28M | $5M | $35M | $70M | |
| Receivables | $3M | $1M | $2M | $3M | $2M | $2M | $2M | $16M | $2M | $837.0K | · | · | · | $25M | $10M | · | |
| Prepaid Expense | $6M | $4M | $4M | $7M | $10M | $7M | $8M | $8M | $7M | $6M | · | $6M | $6M | $4M | $5M | $3M | |
| Other Current Assets | · | · | $2M | · | · | · | $3M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $125M | $147M | $203M | $220M | $228M | $245M | $277M | $373M | $382M | $409M | · | $262M | $282M | $303M | $147M | $152M | |
| PP&E (Net) | $11M | $12M | $13M | $13M | $14M | $14M | $14M | $15M | $16M | $17M | · | $17M | $17M | $17M | $18M | $19M | |
| PP&E (Gross) | · | · | $32M | · | · | · | $30M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $19M | · | · | · | $16M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $214.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $198M | $219M | $252M | $288M | $322M | $353M | $393M | $426M | $436M | $470M | · | $295M | $316M | $336M | $182M | $189M | |
| Accounts Payable | $2M | $3M | $5M | $2M | $2M | $3M | $4M | $3M | $3M | $8M | · | $3M | $2M | $4M | $1M | $1M | |
| Accrued Liabilities | $8M | $7M | $12M | $15M | $12M | $9M | $14M | $11M | $10M | $8M | · | $11M | $9M | $8M | $13M | $7M | |
| Current Liabilities | $17M | $17M | $27M | $35M | $42M | $40M | $50M | $44M | $40M | $73M | · | $62M | $45M | $20M | $73M | $98M | |
| Capital Leases | $26M | $27M | $29M | $31M | $33M | $35M | $36M | $38M | $40M | $42M | · | $18M | $19M | $20M | $21M | $22M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $39M | $41M | $43M | · | $19M | $20M | $21M | $22M | $23M | |
| Total Liabilities | $43M | $46M | $56M | $68M | $78M | $81M | $93M | $96M | $101M | $129M | · | $118M | $117M | $119M | $103M | $129M | |
| Common Stock | $61.0K | $60.0K | $59.0K | $56.0K | $56.0K | $55.0K | $55.0K | $55.0K | $54.0K | $54.0K | · | $44.0K | $44.0K | $43.0K | $38.0K | $38.0K | |
| Paid-in Capital | $653M | $648M | $642M | $638M | $635M | $630M | $626M | $622M | $619M | $614M | · | $494M | $491M | $487M | $450M | $448M | |
| Retained Earnings | $-498M | $-474M | $-446M | $-418M | $-391M | $-357M | $-326M | $-292M | $-283M | $-273M | · | $-318M | $-292M | $-269M | $-370M | $-388M | |
| AOCI | $-421.0K | $-263.0K | $32.0K | $7.0K | $-221.0K | $-199.0K | $-407.0K | $-33.0K | $-522.0K | $-506.0K | · | $-248.0K | $-133.0K | $-132.0K | $-337.0K | $-364.0K | |
| Stockholders' Equity | $154M | $174M | $196M | $220M | $244M | $273M | $300M | $330M | $335M | $341M | $236M | $176M | $199M | $217M | $80M | $60M | |
| Liabilities + Equity | $198M | $219M | $252M | $288M | $322M | $353M | $393M | $426M | $436M | $470M | · | $295M | $316M | $336M | $182M | $189M | |
| Shares Outstanding | 61,273,390 | 60,310,526 | 59,047,860 | 55,482,262 | 55,434,956 | 55,209,485 | 54,731,316 | 54,542,048 | 54,472,113 | 54,318,133 | · | 43,909,161 | 43,759,409 | 43,435,889 | 38,520,336 | 38,439,251 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $4M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-26M | $-33M | $-30M | $-31M | $-33M | $-38M | $-15M | $-28M | $-32M | $59M | $-24M | $-21M | $-835.0K | $124M | $-16M | $-18M | |
| CapEx | $0 | $14.0K | $626.0K | $207.0K | $1M | $658.0K | $155.0K | $258.0K | $967.0K | $2M | $755.0K | $782.0K | $1M | $509.0K | $278.0K | $1M | |
| Investing Cash Flow | $15M | $8M | $47M | $35M | $2M | $41M | $-27M | $64M | $-36M | $-96M | $27M | $-158M | $-25M | $14M | $35M | $-36M | |
| Stock Issued | $3M | $3M | · | · | · | · | $0 | $0 | $0 | $93M | · | · | · | · | · | · | |
| Net Stock Activity | · | $3M | · | · | · | · | · | · | · | $93M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $3M | $136.0K | $85.0K | $513.0K | $82.0K | $574.0K | $14.0K | $571.0K | $113M | $460.0K | $331.0K | $2M | $31M | $15.0K | $807.0K | |
| Net Change in Cash | $-8M | $-22M | $17M | $4M | $-31M | $3M | $-41M | $36M | $-67M | $76M | $4M | $-179M | $-24M | $169M | $19M | $-54M | |
| Free Cash Flow | · | $-33M | · | · | · | $-39M | · | · | · | $57M | · | · | · | $123M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -833.9% | -1167.4% | · | -228.9% | -704.3% | -536.0% | · | -56.0% | -50.8% | -82.9% | · | -639.5% | -523.9% | 81.7% | 35.1% | -2720.1% | |
| Net Margin | -773.2% | -1077.4% | · | -208.7% | -642.0% | -479.2% | · | -36.7% | -34.3% | -58.1% | · | -561.4% | -457.6% | 82.4% | 42.9% | -2680.8% | |
| Pretax Margin | -772.6% | -1076.9% | · | -208.1% | -641.7% | -478.7% | · | -36.5% | -34.2% | -58.0% | · | -565.2% | -456.4% | 82.9% | · | · | |
| EBITDA Margin | -833.9% | -1167.4% | · | -228.9% | -704.3% | -536.0% | · | -56.0% | -50.8% | -82.9% | · | -639.5% | -523.9% | 81.7% | 35.1% | -2720.1% | |
| ROA | -9.4% | -9.8% | · | -7.8% | -8.8% | -7.5% | · | -2.5% | -2.7% | -2.8% | · | -10.9% | -8.8% | 44.3% | 9.6% | -9.6% | |
| ROE | -12.3% | -12.5% | · | -10.1% | -11.5% | -10.1% | · | -3.6% | -3.8% | -4.1% | · | -20.2% | -17.1% | 84.7% | 21.1% | -22.4% | |
| ROIC | -17.1% | -17.4% | · | -14.0% | -15.0% | -12.7% | · | -4.2% | -4.5% | -4.8% | · | -16.6% | -12.8% | 56.3% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.5 | 8.4 | · | 6.2 | 5.4 | 6.1 | · | 8.4 | 9.5 | 5.6 | · | 4.2 | 6.2 | 15.2 | 2.0 | 1.5 | |
| Quick Ratio | 7.1 | 8.2 | · | 6.0 | 5.2 | 5.9 | · | 8.2 | 9.3 | 5.5 | · | 4.1 | 6.0 | 15.0 | 1.9 | 1.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.5 | 0.2 | 0.0 | |
| Receivables Turnover | 1.4 | 1.7 | · | 1.4 | 3.1 | 5.3 | · | 1.9 | 34.8 | 1.5 | · | · | · | 12.0 | 8.2 | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.52 | $2.88 | · | $3.96 | $4.40 | $4.94 | · | $6.06 | $6.16 | $6.28 | · | $4.01 | $4.55 | $5.00 | $2.07 | $1.56 | |
| Revenue / Share | $0.05 | $0.04 | · | $0.23 | $0.09 | $0.11 | · | $0.43 | $0.51 | $0.34 | · | $0.11 | $0.11 | $3.57 | $1.04 | $0.02 | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.65 | · | · | · | $1.03 | · | · | · | $2.93 | · | · | |
| Cash / Share | $0.58 | $0.72 | · | $0.81 | $0.79 | $1.35 | · | $2.06 | $1.40 | $2.63 | · | $1.49 | $5.58 | $6.18 | $2.51 | $2.04 | |
| EPS (TTM) | $-1.81 | $-1.98 | · | $-2.16 | $-1.85 | $-1.46 | · | $0.59 | $0.16 | $-0.17 | · | $1.24 | $2.28 | $2.29 | $-0.45 | $-1.57 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $34M | $36M | · | $31M | $43M | $67M | · | $164M | $144M | $119M | · | $158M | $195M | $191M | $71M | $31M | |
| Net Income TTM | $-108M | $-117M | · | $-127M | $-108M | $-85M | · | $26M | $9M | $-3M | · | $52M | $96M | $99M | $-17M | $-60M | |
| Market Cap | $214M | $233M | · | $259M | $172M | $187M | · | $319M | $431M | $506M | · | $340M | $501M | $335M | $228M | $227M | |
| P/E | -1.9 | -1.9 | · | -2.2 | -1.7 | -2.3 | · | 9.9 | 49.4 | -54.8 | · | 6.2 | 5.0 | 3.4 | -13.2 | -3.8 | |
| P/S | 6.2 | 6.4 | · | 8.3 | 4.0 | 2.8 | · | 1.9 | 3.0 | 4.2 | · | 2.1 | 2.6 | 1.8 | 3.2 | 7.3 | |
| P/B | 1.4 | 1.3 | · | 1.2 | 0.7 | 0.7 | · | 1.0 | 1.3 | 1.5 | · | 1.9 | 2.5 | 1.5 | 2.9 | 3.8 | |
| P / Tangible Book | 1.4 | 1.3 | · | 1.2 | 0.7 | 0.7 | · | 1.0 | 1.3 | 1.5 | · | 1.9 | 2.5 | 1.5 | 2.9 | 3.8 | |
| P / Cash Flow | · | -7.0 | · | · | · | -4.9 | · | · | · | 8.6 | · | · | · | 2.7 | · | · | |
| Earnings Yield | -51.7% | -51.3% | · | -46.2% | -59.5% | -43.2% | · | 10.1% | 2.0% | -1.8% | · | 16.0% | 19.9% | 29.7% | -7.6% | -26.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $40M | $80M | $250M | $41M | $37M |
| Operating Margin % | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% |
| Net Income | $-120M | $-65M | $132M | $-46M | $-71M |
| Diluted EPS | $-2.04 | $-1.13 | $2.97 | $-1.21 | $-1.89 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 7.6 | 5.6 | 5.0 | 1.7 | 2.7 |
| Quick Ratio | 7.5 | 5.4 | 4.8 | 1.6 | 2.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-135M | $-19M | $75M | $-15M | $-55M |
Institutional owners (13F) 149 filers · $135.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
149
Value held
$135.5M
New positions
22
Exited positions
16
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 22 (-10 vs prior Q) | 16 (0 vs prior Q) | 58 (+12 vs prior Q) | 35 (0 vs prior Q) | +1.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $18,102,222 | 5,172,063 | 13.36% | Shares |
| MILLENNIUM MANAGEMENT LLC | $15,550,328 | 4,442,951 | 11.48% | Shares |
| VANGUARD GROUP INC | $12,837,282 | 3,266,484 | 9.47% | Shares |
| ARMISTICE CAPITAL, LLC | $12,026,000 | 3,436,000 | 8.87% | Shares |
| Vestal Point Capital, LP | $9,187,500 | 2,625,000 | 6.78% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,209,859 | 2,345,674 | 6.06% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,658,199 | 1,330,492 | 3.44% | Shares |
| Opaleye Management Inc. | $4,147,500 | 1,185,000 | 3.06% | Shares |
| STATE STREET CORP | $3,767,477 | 1,076,422 | 2.78% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,319,810 | 948,517 | 2.45% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $2,933,984 | 838,184 | 2.17% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,835,319 | 810,091 | 2.09% | Shares |
| CITADEL ADVISORS LLC | $2,744,235 | 784,067 | 2.03% | Shares |
| MORGAN STANLEY | $2,440,672 | 697,334 | 1.80% | Shares |
| Erste Asset Management GmbH | $2,287,262 | 638,900 | 1.69% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,733,326 | 495,236 | 1.28% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $1,496,439 | 427,554 | 1.10% | Shares |
| DIADEMA PARTNERS LP | $1,447,747 | 413,642 | 1.07% | Shares |
| NORTHERN TRUST CORP | $1,441,311 | 411,803 | 1.06% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $1,246,383 | 356,109 | 0.92% | Shares |
| GOLDMAN SACHS GROUP INC | $1,184,670 | 338,477 | 0.87% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,180,638 | 337,325 | 0.87% | Shares |
| Fiduciary Trust Co | $1,170,390 | 334,397 | 0.86% | Shares |
| JPMORGAN CHASE & CO | $988,836 | 276,211 | 0.73% | Shares |
| Point72 Asset Management, L.P. | $826,291 | 236,083 | 0.61% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $808,770 | 231,077 | 0.60% | Shares |
| Seven Fleet Capital Management LP | $771,860 | 230,406 | 0.57% | Shares |
| Invesco Ltd. | $743,222 | 212,349 | 0.55% | Shares |
| Qube Research & Technologies Ltd | $679,172 | 194,049 | 0.50% | Shares |
| FMR LLC | $615,537 | 175,868 | 0.45% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $530,079 | 151,451 | 0.39% | Shares |
| DIADEMA PARTNERS LP | $525,000 | 150,000 | 0.39% | Call option |
| AMERICAN CENTURY COMPANIES INC | $514,059 | 146,874 | 0.38% | Shares |
| Bank of New York Mellon Corp | $512,946 | 146,556 | 0.38% | Shares |
| D. E. Shaw & Co., Inc. | $503,973 | 143,992 | 0.37% | Shares |
| Altshuler Shaham Ltd | $497,700 | 142,200 | 0.37% | Shares |
| MARSHALL WACE, LLP | $487,980 | 139,422 | 0.36% | Shares |
| WELLS FARGO & COMPANY/MN | $437,647 | 125,042 | 0.32% | Shares |
| Susquehanna Portfolio Strategies, LLC | $431,193 | 123,198 | 0.32% | Shares |
| Privium Fund Management B.V. | $420,000 | 120,000 | 0.31% | Shares |
| Nuveen, LLC | $409,851 | 117,100 | 0.30% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $391,954 | 111,987 | 0.29% | Shares |
| CITADEL ADVISORS LLC | $372,400 | 106,400 | 0.27% | Call option |
| Persistent Asset Partners Ltd | $365,901 | 104,543 | 0.27% | Shares |
| BARCLAYS PLC | $357,716 | 102,204 | 0.26% | Shares |
| Verition Fund Management LLC | $350,000 | 100,000 | 0.26% | Call option |
| Patriot Financial Group Insurance Agency, LLC | $336,175 | 96,050 | 0.25% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $318,147 | 90,899 | 0.23% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $306,107 | 87,459 | 0.23% | Shares |
| ALLIANCEBERNSTEIN L.P. | $266,533 | 69,050 | 0.20% | Shares |
Company insiders 35 insiders · 17 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Alfred Sandrock | President and CEO | April 2, 2026 S | 472,549 | 0 | 3 | $-144,441 |
| Andre Turenne | President & CEO | March 19, 2021 A | 322,375 | 0 | 0 | $0 |
| Nathan D. Jorgensen | Chief Financial Officer | Feb. 24, 2026 S | 151,416 | 0 | 2 | $-54,241 |
| Peter P. Pfreundschuh | Chief Financial Officer | Feb. 21, 2024 S | 175,669 | 0 | 0 | $0 |
| Jane Henderson | Sr. V.P. & CFO, Corp. Dev. | March 23, 2018 M | 0 | 0 | 0 | $0 |
| Jeff Goater | Chief Financial Officer | Feb. 1, 2016 A | · | 0 | 0 | $0 |
| Robin Swartz | COO & CBO | Feb. 24, 2026 S | 199,738 | 0 | 3 | $-55,292 |
| Matthew P. Ottmer | Chief Operating Officer | Jan. 21, 2020 S | 26,276 | 0 | 0 | $0 |
| Gregory L. Shiferman | SVP and General Counsel | April 1, 2026 A | 50,000 | 0 | 0 | $0 |
| Todd Alfred Carter | Chief Scientific Officer | Feb. 24, 2026 S | 145,718 | 0 | 3 | $-40,620 |
| Toby Ferguson | Chief Medical Officer | Feb. 6, 2026 A | 183,914 | 0 | 0 | $0 |
| Sandell Jacquelyn Fahey | Chief Legal Officer | Feb. 21, 2025 A | 123,143 | 0 | 0 | $0 |
| Robert W. Hesslein | Senior VP & General Counsel | March 20, 2023 S | 102,200 | 0 | 0 | $0 |
| Julie Burek | VP, Finance | March 21, 2022 S | 52,458 | 0 | 0 | $0 |
| Omar Khwaja | Chief Medical Officer and Head of Research & Development. | May 21, 2021 S | 120,509 | 0 | 0 | $0 |
| Dinah Sah Ph.D. | Chief Scientific Officer | Jan. 11, 2019 A | 163,688 | 0 | 0 | $0 |
| Bernard Ravina | Chief Medical Officer | April 10, 2018 S | 0 | 0 | 0 | $0 |
| Jude Onyia | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Nancy Vitale | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Grace Colon | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Steven Hyman | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Catherine J Mackey | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Michael J Higgins | Director | June 9, 2026 A | 31,314 | 0 | 0 | $0 |
| Glenn Pierce | Director | June 9, 2026 A | 16,788 | 0 | 0 | $0 |
| James A Geraghty | Director | June 9, 2026 A | 76,588 | 0 | 0 | $0 |
| George A Scangos | Director | June 9, 2026 A | · | 0 | 0 | $0 |
| Steven M Paul | Director | June 3, 2021 A | 872,351 | 0 | 0 | $0 |
| Mark J Levin | Director | June 3, 2021 A | 6,391,176 | 0 | 0 | $0 |
| Wendy L Dixon | Director | June 4, 2020 A | · | 0 | 0 | $0 |
| Perry A Karsen | Director | June 13, 2019 A | · | 0 | 0 | $0 |
| NEUROCRINE BIOSCIENCES INC | 10% owner | Feb. 23, 2023 P | 8,575,316 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10% owner | Jan. 11, 2023 S | 3,851,507 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) L.P. | 10% owner | Nov. 16, 2015 C | 470,588 | 0 | 0 | $0 |
| Allison Dorval | · | March 19, 2021 A | 109,894 | 0 | 0 | $0 |
| Sanofi | · | Nov. 10, 2015 C | 2,477,941 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 22 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.41% | 34,783 SH | Oct. 2, 2026 | Daily |
| IBRN · iShares Trust | 0.18% | 4,106 SH | Sept. 11, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.07% | 70,113 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.04% | 183,069 SH | Sept. 11, 2026 | Daily |
| IBB · iShares Trust | 0.01% | 371,337 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.01% | 4,238 SH | Oct. 2, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 301,636 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 47,877 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 82,492 SH | Oct. 2, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,350,887 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 25,102 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 84,113 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2,700 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 6,400 NS | July 31, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 9,664 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 39,859 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 9,213 SH | Sept. 3, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 5,408 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 613,128 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,671,885 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,515 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 487,012 SH | Sept. 11, 2026 | Daily |
VYGR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 17 analysts
BUY
Median target
$12.00
+389.8%
8 47.1%
Strong Buy
8 47.1%
Buy
1 5.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-10-01Mean target $14.89 +507.7%
← Below all targets
Current price $2.45
Low$8.00
Mean$14.89
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026